文献速递消化系统肿瘤

单细胞组学:胰腺癌早期检测的新视角?

Single-cell omics: a new perspective for early detection of pancreatic cancer?
PubMed 文献 · Eur J Cancer · 2023-06-16

本综述探讨液体活检用于胰腺癌早期检测的潜在优势,重点关注循环肿瘤细胞(CTC)及其单细胞组学分析;CTC 可提供诊断、预后和治疗策略信息,在胰腺前驱病变受试者血中亦可检出,提示其作为无创早期检测工具的适用性。

要点

  • CTC 可来自原发和转移瘤灶,为诊断、预后和治疗策略制定提供信息。
  • 胰腺前驱病变受试者血中已可检出 CTC,提示其作为无创早期检测工具的适用性。
  • 系列采样联合单细胞分辨率分析 CTC 有助于解析肿瘤异质性及治疗反应。

核心结论

  • CTC 的单细胞组学分析为胰腺癌早期检测、异质性解析和个体化治疗提供新视角。

研究设计与样本

  • 综述,探讨液体活检尤其是 CTC 及其单细胞组学分析用于胰腺癌早期检测的潜在优势。

主要发现

  • CTC 起源于原发和转移瘤灶,提供诊断、预后和治疗策略信息。
  • 胰腺前驱病变受试者血中已检出 CTC,提示其作为无创早期检测工具的适用性。
  • CTC 作为完整细胞可提供基因组、转录组、表观遗传和蛋白质组信息。
  • 系列采样联合单细胞分辨率分析 CTC 有助于解析个体患者及患者间的肿瘤异质性,并为疾病进展和治疗反应中的癌症演化提供新见解。
  • 利用 CTC 无创追踪癌症特征(包括干性、转移潜能和免疫靶点表达)可提供重要且易获取的分子信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreatic cancer is one of the most lethal cancers, mostly due to late diagnosis and limited treatment options. Early detection of pancreatic cancer in high-risk populations bears the potential to greatly improve outcomes, but current screening approaches remain of limited value despite recent technological advances. This review explores the possible advantages of liquid biopsies for this application, particularly focusing on circulating tumour cells (CTCs) and their subsequent single-cell omics analysis. Originating from both primary and metastatic tumour sites, CTCs provide important information for diagnosis, prognosis and tailoring of treatment strategies. Notably, CTCs have even been detected in the blood of subjects with pancreatic precursor lesions, suggesting their suitability as a non-invasive tool for the early detection of malignant transformation in the pancreas. As intact cells, CTCs offer comprehensive genomic, transcriptomic, epigenetic and proteomic information that can be explored using rapidly developing techniques for analysing individual cells at the molecular level. Studying CTCs during serial sampling and at single-cell resolution will help to dissect tumour heterogeneity for individual patients and among different patients, providing new insights into cancer evolution during disease progression and in response to treatment. Using CTCs for non-invasive tracking of cancer features, including stemness, metastatic potential and expression of immune targets, provides important and readily accessible molecular insights. Finally, the emerging technology of ex vivo culturing of CTCs could create new opportunities to study the functionality of individual cancers at any stage and develop personalised and more effective treatment approaches for this lethal disease.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Wang Q, Šabanović B, Awada A, et al. Single-cell omics: a new perspective for early detection of pancreatic cancer? Eur J Cancer. 2023. PMID: 37413845. doi:10.1016/j.ejca.2023.112940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。